ESTRO37_ProgrammeBook

16:25 > Validation of the reRT risk score (RRRS) in glioma patients: A multicenter DKTK/ROG analysis

M. Niyazi (Germany), S. Adeberg, D. Kaul, A.L. Boulesteix, N. Bougatf, D.F. Fleischmann, A. Grün, A. Krämer, C. Rödel, F. Eckert, F. Paulsen, K.A. Kessel, S.E. Combs, O. Oehlke, A.L. Grosu, A. Seidlitz, A. Lattermann, M. Krause, M. Baumann, M. Guberina, M. Stuschke, V. Budach, C. Belka, J. Debus

MONDAY 23 APRIL 2018

OC-0588

16:35 > Phase-II parallel non-randomized/observation study (EORTC 22042-26042) for non-benign meningiomas

D.C. Weber (Switzerland), C. Ares, S. Villa, S.M. Peerdeman, L. Renard, B.G. Baumert, A. Lucas, J.J. Stelmes, S. Collette, R. Miralbell

OC-0589

16:45 > Screening MRI for radiation-induced meningioma in childhood cancer survivors with prior cranial RT J. Co, M. Swain, L. Murray, S. Ahmed, N. Laperriere, D. Tsang, D. Hodgson (Canada) 16:55 > Phase III randomized trial comparing two modalities of RS for brain metastases: Gammaknife vs Linac V. Palumbo, P. Navarria (Italy), S. Tomatis, E. Clerici, G.A. Carta, P. Picozzi, P. Mancosu, M. Scorsetti 17:05 > Hypofractionated stereotactic radiotherapy of large brain metastases: analysis of 350 patients P. Ivanov, I. Zubatkina (Russian Federation), A. Kuzmin, D. Nikitin, V. Krasnyuk, G. Andreev, F. Schepinov

OC-0590

OC-0591

17:15 > Dosimetric analysis of local failures in skull-base chordoma/ chondrosarcoma following proton therapy

L. Basler (Switzerland), R. Poel, A. Bolsi, A.J. Lomax, S. Tanadini-Lang, M. Guckenberger, D.C. Weber

OC-0593

SCIENTIFIC PROGRAMME | Programme and Exhibition Guide

166